Europe Measles, Mumps And Rubella Vaccines Market (2025-2031) | Analysis, Outlook, Share, Companies, Industry, Value, Revenue, Trends, Growth, Size & Forecast

Europe Measles, Mumps and Rubella Vaccines Market Highlights

Report Name	Europe Measles, Mumps and Rubella Vaccines Market
Forecast period	2025-2031
Forecast Size	USD 1.5 billion by 2031
CAGR	4.6%
Growing Sector	Hospitals

Topics Covered in the Europe Measles, Mumps and Rubella Vaccines Market Report

Europe Measles, Mumps and Rubella Vaccines Market report thoroughly covers the market By Countries, By Product Type, and By End Users. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

Europe Measles, Mumps and Rubella Vaccines Market Size & Analysis

The Europe measles, mumps and rubella vaccines market is projected to reach USD 1.5 billion by the year 2031, with a CAGR of 4.6% during the forecast period (2025-2031). The rise in government initiatives towards immunization programs as well as technological advancements in vaccine production are major factors driving the market growth.

Europe Measles, Mumps and Rubella Vaccines Market Synopsis

The Europe measles, mumps and rubella (MMR) vaccines market is expected to experience significant growth in the coming years. This can be attributed to several factors such as increasing government initiatives for immunization, rising awareness about the importance of vaccinations, and advancements in technology.

According to 6Wresearch, the Europe Measles, Mumps and Rubella Vaccines Market Size is expected to reach a significant CAGR of 4.6% during the forecast period 2025-2031. The primary factor driving the growth of the Europe measles, mumps, and rubella vaccines market is the rising awareness about the importance of vaccinations for preventing these diseases. With advancements in medical research and technology, there has been an increase in the availability of safe and effective vaccines, leading to a rise in vaccination rates. Additionally, government initiatives and programs aimed at promoting immunization have also contributed to the growth of this market. apart from this, increasing incidence of measles, mumps, and rubella infections across Europe. Despite being preventable diseases, outbreaks continue to occur due to low vaccination rates in certain regions. As a result, there has been a growing demand for MMR vaccines in order to control these infections.

Despite the positive outlook for the Europe MMR vaccines market, there are some challenges that may hinder its growth. One of the major challenges is vaccine hesitancy among certain populations. Misinformation and mistrust regarding vaccines have led to a decline in vaccination rates in some regions, which can hinder the control of diseases like measles, mumps, and rubella. The high cost of vaccine development and distribution in specific regions further restricts accessibility and affordability for some populations. Lastly, logistical challenges, such as maintaining cold chain storage, add operational hurdles in ensuring vaccines reach remote or underserved areas effectively.

Europe Measles, Mumps and Rubella Vaccines Market Trends

Key trends shaping the Measles, Mumps and Rubella Vaccines Market in Europe include a substantial focus on research and innovation. Manufacturers are investing in next-generation vaccines with improved efficacy, while partnerships between public and private healthcare sectors are driving accessibility. Another notable trend is the collaboration between pharmaceutical companies and local governments to provide cost-effective vaccines to vulnerable populations. Additionally, the widespread adoption of digital health tools and technologies to track vaccination rates has been instrumental in fostering a more data-driven and optimized vaccination ecosystem.

Investment Opportunities in the Europe Measles, Mumps and Rubella Vaccines Market

Investment opportunities in the Europe Measles, Mumps and Rubella Vaccines Market Growth are abundant due to the ongoing expansion of immunization programs. Emerging markets within Europe—especially those in Eastern and Central Europe—offer potential opportunities for vaccine manufacturers and distributors. Investors are also keen on technology-driven health innovations that promise to enhance vaccine outreach efforts. Given the heightened emphasis on controlling preventable diseases like measles, mumps, and rubella, the market has attracted significant attention from both established players and new entrants seeking to capitalize on unmet needs.

Leading Players in the Europe Measles, Mumps and Rubella Vaccines Market

The Europe Measles, Mumps and Rubella Vaccines Market Share is dominated by major pharmaceutical companies, including GlaxoSmithKline, Merck & Co., and Sanofi Pasteur. These key players are at the forefront of innovation in vaccine manufacturing and distribution. Additionally, smaller biotechnology firms are emerging as noteworthy competitors by introducing cost-effective and innovative solutions tailored to the European market's specific needs. Strategic collaborations, joint ventures, and mergers are common strategies among leading companies to expand their footprint and strengthen market dominance.

Government Regulations

Government policies and regulations play a crucial role in shaping the Europe Measles, Mumps, and Rubella vaccines sector. Regulatory agencies like the European Medicines Agency (EMA) ensure the safety and efficacy of vaccines before they are approved for public use. The increased scrutiny around quality control, combined with efforts to standardize vaccination schedules across European Union member states, has significantly influenced market dynamics. Policies emphasizing mandatory vaccinations in certain regions have also contributed to boosting vaccine uptake while addressing public health concerns.

Future Insights of the Europe Measles, Mumps and Rubella Vaccines Market

The future of the Europe Measles, Mumps and Rubella Vaccines Market appears promising, with numerous opportunities for growth driven by technological advancements and concerted global efforts toward eradication goals. The integration of artificial intelligence and machine learning in vaccine research is expected to fast-track the development of improved immunization strategies. Meanwhile, public-private partnerships continue to play a pivotal role in scaling vaccine accessibility while maintaining affordability.

Market Segmentation Analysis 

The report offers a comprehensive study of the subsequent market segments and their leading categories. 

Germany to Dominate the Market- By Countries

Germany is expected to dominate the market due to its well-established healthcare system and high awareness about vaccination among parents.

Combinational vaccines to Dominate the Market- By Product Type

According to Ravi Bhandari, Research Head, 6Wresearch, combinational vaccines segment is expected to dominate the market in the forecast period. This can be attributed to its ability to protect against multiple diseases with a single vaccine dose, making it convenient for both patients and healthcare providers.

Hospitals to Dominate the Market- By End Users

Hospitals are expected to hold a major share of the market among end users due to their advanced healthcare infrastructure and high patient footfall.

Key Attractiveness of the Report

• 10 Years of Market Numbers.
• Historical Data Starting from 2021 to 2024.
• Base Year 2024
• Forecast Data until 2031.
• Key Performance Indicators Impacting the Market.
• Major Upcoming Developments and Projects.

Key Highlights of the Report:

• Europe Measles, Mumps And Rubella Vaccines Market Outlook
• Market Size of Europe Measles, Mumps And Rubella Vaccines Market, 2024
• Forecast of Europe Measles, Mumps And Rubella Vaccines Market, 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Revenues & Volume for the Period 2021 - 2031
• Europe Measles, Mumps And Rubella Vaccines Market Trend Evolution
• Europe Measles, Mumps And Rubella Vaccines Market Drivers and Challenges
• Europe Measles, Mumps And Rubella Vaccines Price Trends
• Europe Measles, Mumps And Rubella Vaccines Porter's Five Forces
• Europe Measles, Mumps And Rubella Vaccines Industry Life Cycle
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Product Type for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Monovalent for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Combinational for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Divalent for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Trivalent for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Germany Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of United Kingdom Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of France Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Italy Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Russia Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Spain Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By End Users for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Hospitals for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Healthcare Centers for the Period 2021 - 2031
• Historical Data and Forecast of Rest of Europe Measles, Mumps And Rubella Vaccines Market Revenues & Volume By Others for the Period 2021 - 2031
• Europe Measles, Mumps And Rubella Vaccines Market - Key Performance Indicators
• Europe Measles, Mumps And Rubella Vaccines Market - Import Export Trade Statistics
• Europe Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment By Countries
• Europe Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment By Product Type
• Europe Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment By End Users
• Europe Measles, Mumps And Rubella Vaccines Market - Top Companies Market Share
• Europe Measles, Mumps And Rubella Vaccines Market - Top Companies Profiles
• Europe Measles, Mumps And Rubella Vaccines Market - Comparison of Players in Technical and Operating Parameters
• Europe Measles, Mumps And Rubella Vaccines Market - Strategic Recommendations

Markets Covered

The market report has been segmented and sub-segmented into the following categories

By Countries

• Germany
• United Kingdom
• France
• Italy
• Russia
• Spain
• Rest of Europe

By Product Type

• Monovalent
• Combinational
• Divalent
• Trivalent
• Others

By End Users

• Hospitals
• Healthcare Centers
• Others